MoonLake Immunotherapeutics
Sector: Manufacturing
Industry: Pharmaceutical Products
38.33
1.36
(3.67%)
Volume:
257,070
52 week range:
31.42 - 58.26
Market Cap:
2.453B
Company Description:
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, or ankylosing spondylitis.